Both in Biotechnology
C4 Therapeutics vs Editas Medicine
Over the past year CCCC returned +29.4% and EDIT returned −15.0%; their daily moves had a correlation of 0.42.
CCCC +29.4% EDIT −15.0%Growth of $1, one year, split-adjusted
| Metric | CCCC | EDIT |
|---|---|---|
| Price | $3.21 | $2.60 |
| Market cap | $394.9M | $399.3M |
| Today | 0.00% | +1.17% |
| 1 month | +7.4% | −6.8% |
| 6 months | +8.1% | −14.5% |
| Year to date | +68.1% | +26.8% |
| 1 year | +23.0% | −15.6% |
| Revenue growth (YoY) | +2.8% | +232.3% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −355.9% | −153.3% |
| P/E (TTM) | — | — |
| Price / sales | 11.3× | 8.5× |
| Net cash | $253.7M | $155.9M |
| Dividend yield | — | — |
| Volatility (60d) | 65.3% | 81.6% |
| Short % of float | 43.4% | 25.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).